Montereau Fault Yonne

Researchers are evaluating the impact of vaccine funding provided by the National Health Insurance on vaccination coverage among patients targeted by current vaccination recommendations. The study focuses on patients seen in outpatient consultations within four healthcare institutions in the Ile-de-France region in France. The project aims to determine if dedicated vaccine funding can improve vaccination rates for vulnerable patients at risk of infections, such as pregnant women for pertussis and eligible patients for pneumococcal vaccination. The study involves several groups including women in the immediate postpartum period, patients eligible for pneumococcal vaccination with specific health coverage, and healthcare providers involved in vaccination efforts. Questionnaires will be used to collect information from patients and healthcare providers. The study will assess vaccination coverage for pertussis and pneumococcal infections at 3 and 18 months, along with evaluating socio-economic factors, changes in healthcare professional practices, and improvements in communication about vaccination status using digital tools. Participants will be monitored through outpatient consultation records and questionnaires. Researchers will measure the number of vaccinated individuals, factors influencing vaccination, and the frequency of vaccination offers and administration by healthcare providers. The study will also observe changes in documentation practices to enhance communication between institutions and primary care. The research is expected to run until July 2027, with a focus on improving vaccine reimbursement and coverage policies based on findings.